Deutsche Bank AG started coverage on shares of Core Laboratories N.V. (NYSE:CLB) in a research report sent to investors on Tuesday, MarketBeat Ratings reports. The firm issued a buy rating and a $109.00 price target on the oil and gas company’s stock.
CLB has been the subject of several other research reports. ValuEngine lowered shares of Core Laboratories N.V. from a hold rating to a sell rating in a research report on Friday, September 1st. Royal Bank Of Canada reduced their price objective on shares of Core Laboratories N.V. from $115.00 to $112.00 and set an outperform rating for the company in a research note on Thursday, September 7th. Credit Suisse Group raised shares of Core Laboratories N.V. from a neutral rating to an outperform rating and set a $110.00 price objective for the company in a research note on Thursday, August 24th. They noted that the move was a valuation call. Cowen and Company reaffirmed a hold rating and set a $100.00 price objective on shares of Core Laboratories N.V. in a research note on Friday, September 1st. Finally, BidaskClub raised shares of Core Laboratories N.V. from a sell rating to a hold rating in a research note on Wednesday, July 5th. Three investment analysts have rated the stock with a sell rating, nine have assigned a hold rating and five have issued a buy rating to the company. The company has a consensus rating of Hold and a consensus price target of $110.91.
Core Laboratories N.V. (NYSE:CLB) last posted its quarterly earnings data on Monday, July 24th. The oil and gas company reported $0.52 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.51 by $0.01. Core Laboratories N.V. had a net margin of 11.80% and a return on equity of 49.29%. The company had revenue of $163.90 million during the quarter, compared to analyst estimates of $168.23 million. During the same quarter last year, the firm posted $0.35 EPS. The business’s revenue for the quarter was up 10.7% on a year-over-year basis.
TRADEMARK VIOLATION WARNING: This news story was posted by Community Financial News and is the sole property of of Community Financial News. If you are viewing this news story on another site, it was copied illegally and republished in violation of US and international trademark & copyright law. The original version of this news story can be viewed at https://www.com-unik.info/2017/10/13/deutsche-bank-ag-begins-coverage-on-core-laboratories-n-v-clb.html.
Hedge funds have recently bought and sold shares of the business. Parallel Advisors LLC lifted its stake in Core Laboratories N.V. by 33.4% during the first quarter. Parallel Advisors LLC now owns 891 shares of the oil and gas company’s stock valued at $101,000 after buying an additional 223 shares in the last quarter. Quantbot Technologies LP purchased a new stake in Core Laboratories N.V. during the first quarter valued at about $106,000. FNY Managed Accounts LLC purchased a new stake in Core Laboratories N.V. during the first quarter valued at about $123,000. The Manufacturers Life Insurance Company lifted its stake in Core Laboratories N.V. by 63.7% during the second quarter. The Manufacturers Life Insurance Company now owns 1,128 shares of the oil and gas company’s stock valued at $114,000 after buying an additional 439 shares in the last quarter. Finally, Shine Investment Advisory Services Inc. purchased a new stake in Core Laboratories N.V. during the second quarter valued at about $134,000.
About Core Laboratories N.V.
Core Laboratories N.V. provides reservoir description, production enhancement and reservoir management services to the oil and gas industry. The Company operates through three segments: Reservoir Description, Production Enhancement and Reservoir Management. The Reservoir Description segment encompasses the characterization of petroleum reservoir rock, fluid and gas samples.
What are top analysts saying about Core Laboratories N.V.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Core Laboratories N.V. and related companies.